How young immune cells can help heal fractures in older adults
The role of macrophage subpopulations in the rejuvenation of fracture repair
This study is looking at how immune cells from younger mice can help heal broken bones faster in older mice, and it hopes to find new ways to improve bone healing for older adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11004081 on NIH RePORTER |
What this research studies
This research investigates how specific immune cells, known as macrophages, from younger mice can enhance the healing process of bone fractures in older mice. By using a method called heterochronic parabiosis, where young and old mice share a blood supply, the study aims to understand how these young macrophages rejuvenate the fracture repair process. The researchers will analyze the origin and function of these macrophages to identify potential therapeutic targets that could improve bone healing in older adults. This approach may lead to new treatments that enhance recovery from fractures, particularly in aging populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who have experienced bone fractures and are at risk for delayed healing or non-union.
Not a fit: Patients who are younger or do not have bone fractures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that significantly improve fracture healing in older adults, reducing complications and the need for surgical interventions.
How similar studies have performed: Previous studies using similar approaches have shown promising results in rejuvenating bone repair, indicating potential for success in this research.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Alman, Benjamin Aaron — Duke University
- Study coordinator: Alman, Benjamin Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.